Infusion of lentiviral TYF-CGD-modified autologous stem cells ( DrugBank: - )
1 disease
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
65 | 原発性免疫不全症候群 | 1 |
65. 原発性免疫不全症候群
臨床試験数 : 500 / 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03645486 (ClinicalTrials.gov) | July 1, 2018 | 24/7/2018 | Lentiviral Gene Therapy for CGD | Lentiviral Gene Therapy for Chronic Granulomatous Disease (CGD) | Chronic Granulomatous Disease | Genetic: Infusion of lentiviral TYF-CGD-modified autologous stem cells | Shenzhen Geno-Immune Medical Institute | NULL | Recruiting | N/A | N/A | All | 10 | N/A | China |